ORIC Pharmaceuticals (ORIC) lost ~22% in extended trading after the company reported data from a Phase 1b trial for its prostate cancer therapy rinzimetostat (ORIC-944) developed in combination with ...

Several experimental prostate cancer drugs have produced striking results in early-stage clinical trials, with at least one ...

Prostate cancer affects one in five Australian men, making it the most common cancer in the country. Now, researchers at the ...

Scientists have identified a new cell type and discovered that many normal-looking prostate cells already harbour cancer-related changes.Prostate ...

When you’re diagnosed with prostate cancer at an early stage, usually stage I or II, it means the disease hasn't spread outside your prostate gland. That means you have a few good treatment options to ...

Prostate cancer is one of the most common cancers diagnosed in men. Although it is the second-leading cause of cancer-related deaths for men in the U.S., it is also highly treatable, especially when ...

Prostate cancer is the most common cancer in men throughout the United States. Most men do not realize they have cancer due to its slow growing nature and reduced symptoms. Increased risk factors ...

A multi-institutional study led by Mayo Clinic and published in Cell Reports Medicine reports that pairing a next-generation immunotherapy with standard hormone therapy before surgery may help ...

Early detection of prostate cancer is crucial, as this disease can be so indolent (slow-growing) that patients don't realize they have it until it causes significant problems. The good news is that if ...

The statistics are sobering and undeniable — African American men develop prostate cancer at twice the rate of white men and are more likely to die from the disease. This reality makes understanding ...